(Q46819442)

25 December 2017

title

The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach (English)

1 reference

25 December 2017

0 references

0 references

1 reference

2

Geoffrey K Isbister

1 reference

25 December 2017

4

Stephen B Duffull

1 reference

25 December 2017

Lena E Friberg

series ordinal

1

object named as

Lena E Friberg

1 reference

25 December 2017

author name string

L Peter Hackett

series ordinal

3

1 reference

25 December 2017

publication date

1 August 2005

1 reference

25 December 2017

Journal of Pharmacokinetics and Pharmacodynamics

published in

1 reference

25 December 2017

volume

32

1 reference

25 December 2017

issue

3-4

1 reference

25 December 2017

page(s)

571-605

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s10928-005-0022-6

exact match

0 references

cites work

Citalopram Therapy for Depression

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-005-0022-6

Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-005-0022-6

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-005-0022-6

Multiple-dose activated charcoal and enhancement of systemic drug clearance: summary of studies in animals and human volunteers.

21 January 2018

1 reference

12 December 2020

Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram

1 reference

12 December 2020

Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects.

1 reference

12 December 2020

Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance

1 reference

12 December 2020

Steady-state pharmacokinetics of citalopram in young and elderly subjects

1 reference

12 December 2020

Population one-compartment pharmacokinetic analysis with missing dosage data

1 reference

12 December 2020

Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans

1 reference

12 December 2020

A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose

1 reference

12 December 2020

Analysis of population pharmacokinetic data using NONMEM and WinBUGS.

1 reference

12 December 2020

Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?

1 reference

12 December 2020

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects

1 reference

12 December 2020

Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients

1 reference

12 December 2020

The kinetics of citalopram: single and multiple dose studies in man

1 reference

12 December 2020

Kinetics of citalopram in elderly patients

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

1 reference

12 December 2020

Bayesian analysis of population PK/PD models: general concepts and software

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

12 December 2020

Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists

1 reference

12 December 2020

Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis

1 reference

12 December 2020

A randomized clinical trial of activated charcoal for the routine management of oral drug overdose

1 reference

12 December 2020

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

1 reference

12 December 2020

Citalopram and Torsades de Pointes. A case report

1 reference

12 December 2020

Kinetics of citalopram in man; plasma levels in patients

1 reference

12 December 2020

Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.

1 reference

12 December 2020

An extended interval dosing method for gentamicin in neonates

1 reference

12 December 2020

Routine Therapeutic Drug Monitoring in Patients Treated with 10-360 mg/day Citalopram

1 reference

12 December 2020

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

1 reference

12 December 2020

Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage

1 reference

12 December 2020

Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning

1 reference

12 December 2020

Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

1 reference

12 December 2020

Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study

1 reference

12 December 2020

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

1 reference

12 December 2020

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

1 reference

12 December 2020

Lack of adverse interactions between concomitantly administered selegiline and citalopram

1 reference

12 December 2020

Therapeutic drug monitoring in drug overdose

1 reference

12 December 2020

Estimation of population pharmacokinetic parameters in the presence of non-compliance

1 reference

12 December 2020

Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram

1 reference

12 December 2020

Preliminary studies of the kinetics of citalopram in man

1 reference

12 December 2020

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

1 reference

12 December 2020

Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel

1 reference

12 December 2020

Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.

1 reference

12 December 2020

Uising WinBUGS to fit nonlinear mixed models with an application to pharmacokinetic modelling of insulin response to glucose challenge in sheep exposed antenatally to glucocorticoids

1 reference

12 December 2020

Fatal overdose with citalopram.

1 reference

12 December 2020

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

1 reference

12 December 2020

10.1007/S10928-005-0022-6

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017